期刊文献+

PPARγ2基因多态性与子宫内膜异位症的关系

下载PDF
导出
摘要 近年对于子宫内膜异位症(EMs)的基础研究转向其遗传易感性,即基因的差异。过氧化物酶体增殖激活受体γ2(PPAR-γ2)有抑制炎症反应的作用,与脂代谢、糖代谢等有关。PPAR-γ2基因的突变可导致其所编码蛋白构象的改变,从而导致蛋白活性降低,失去对炎症的抵抗作用。研究发现该基因突变与EMs的发生有相关性。PPARγ激动剂可以抑制炎症反应,用PPARγ激动剂治疗EMs的动物实验证实该剂对EMs有效,美国密歇根大学已开始进行该药的临床试验。就PPAR-γ2基因与EMs的关系进行综述。
出处 《国外医学(妇产科学分册)》 2006年第4期289-292,共4页 Foreign Medical Sciences(Obstet Gynecol Fascicle)
  • 相关文献

参考文献20

  • 1Dogan S,Machicao F,Wallwiener D,et al.Association of peroxisome proliferator-activated receptor gamma 2 Pro-12-Ala polymorphism with endometriosis.Fertil Steril,2004,81(5):1411-1413
  • 2Ghoussaini M,Meyre D,Lobbens S,et al.Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population.BMC Med Genet,2005,6:11
  • 3Buzzetti R,Perone A,Ribaudo MC,et al.The common PPAR-gamma2Pro12Ala variant is associated with greater insulin sensitivity.Eur J Hum Genet,2004,12(12):1050-1054
  • 4Drori S,Girnun GD,Tou L,et al.Hic-5 regulates an epithelial program mediated by PPAR gamma.Genes Dev,2005,19(3):362-375
  • 5Zhang GY,Ahmed N,Riley C,et al.Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma.BaJ Cancer,2005,17,92(1):113-119
  • 6Memisoglu A,Hankinson SE,Manson JA,et al.Lack of association of the codon 12 polymorphism of the peroxisome proliferators-actvated receptor-gamma gene with breast cancer and body mass.Pharmacogenetics,2002,12(8):597-603
  • 7Wanichkul T,Han S,Huang RP,et al.Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells.Fertil Steril,2003,79[Suppl 1]:763-769
  • 8Hornung D,Shao VA,Vigne JL,et al.Thiazolidinedione inhibition of peritoneal inflammation.Gynecol Obstet Invest,2003,55 (1):20-24
  • 9Yu J,Qiao L,Zimmermann L,et al.Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.Hepatology,2006,43(1):134-143
  • 10Han S,Roman J.Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.Mol Cancer Ther,2006,5(2):430-437

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部